<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">455</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285â€“496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 391.160 L98.110 391.160 "/>
  <g begin="text">
   <text y="76.959" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="76.959" x="107.983,112.852,117.352,119.485,121.987,126.487,130.987,134.983,138.484,140.986,143.488,147.988,151.984,154.486,158.482,160.615,164.116,170.119,175.789,178.786,183.286,186.283,190.279,194.779,198.775,201.277,205.273,209.773,213.769,217.765,220.015,222.148,224.65,231.652,236.152,240.148,244.144,246.646,248.779,253.279,256.276,258.409,262.909,266.905,271.405,275.905,279.901,282.898,285.031,289.027,293.527,298.027" svgx:width="0.61,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.39,0.67,0.72,0.33,0.5,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.44,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To investigate JCV-prevalence, impact of gender and </text>
   <text y="87.957" x="62.362,66.358,70.858,74.854,77.104,79.354,83.35,87.85,92.35,94.6,97.102,101.602,103.852,107.848,112.348,119.35,123.85,127.846,130.843,134.839,137.089,141.589,144.586,148.582,153.082,155.584,159.58,162.082,164.584,169.084,173.08,175.33,179.83,183.826,186.328,190.828,194.824,197.074,200.071,204.571,207.568,209.818,214.318,216.82,219.655,222.652,226.648,229.645,233.641,238.141,240.643,242.893,246.889,251.389,253.891,256.888,261.388,264.223,267.22,270.217,272.719,277.219,281.719,284.221,288.217,292.213,295.714" svgx:width="0.44,0.5,0.44,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.25,0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.44,0.5,0.28,0.33,0.5,0.33,0.33,0.33,0.28,0.5,0.5,0.28,0.44,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">age, and to compare predictive value for different cut-off-indices.</text>
   <text y="98.955" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="98.955" x="101.287,105.787,110.863,115.363,119.863,124.363,126.793,131.293,135.289,137.791,140.293,144.289,148.789,151.291,154.792,157.222,160.219,164.719,169.219,173.719,176.149,179.146,183.142,190.144,194.14,196.642,200.638,202.888,205.318,209.818,214.318,216.748,223.75,227.746,230.248,234.244,237.241,239.671,243.667,246.169,248.599,251.101,255.601,259.597,262.027,266.527,271.027,273.529,278.029,282.025,284.527,287.029,291.025,295.525,298.027" svgx:width="0.5,0.56,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.5,0.25,0.33,0.44,0.78,0.44,0.28,0.44,0.25,0.25,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.33,0.25,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">n=143 patients (107 female, 36 male) at the outpatient </text>
   <text y="109.953" x="62.362,66.358,68.86,71.362,75.862,78.364,82.36,84.349,87.346,91.846,94.843,96.832,103.834,108.334,110.836,113.338,115.84,120.34,122.842,126.838,128.827,132.328,136.324,138.826,142.822,145.819,150.319,153.82,156.322,159.823,161.812,164.314,168.814,170.803,173.8,178.3,182.8,186.301,190.801,193.798,198.298,202.294,206.794,209.044,210.538,217.036,221.536,225.037,227.539,230.536,233.038,237.034,239.023,243.523,247.519,252.019,256.015,258.004,262.504,266.5,270.496,274.996,276.985,279.487,283.483,286.984,289.486,293.482,297.982" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.25,0.33,0.5,0.33,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.28,0.5,0.25,0.33,0.5,0.5,0.39,0.5,0.33,0.5,0.44,0.5,0.25,0.25,0.72,0.5,0.39,0.28,0.33,0.28,0.44,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.44,0.44,0.5,0.25,0.28,0.44,0.39,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinic for multiple sclerosis in Innsbruck, Austria have been tested </text>
   <text y="120.951" x="62.362,65.359,69.859,72.856,74.917,81.415,85.915,88.417,90.919,93.916,97.417,103.42,109.756,111.817,118.315,122.815,125.317,127.819,132.319,136.819,141.319,143.821,147.817,151.318,153.568,156.124,161.623,165.619,170.119,174.619,177.616,181.612,184.114,188.614,191.611,196.111,198.667,201.169,205.165,208.666,211.168,213.724,218.224,222.724,225.28,228.781,234.784,240.454,243.451,248.455,250.957,253.954,257.95,260.452,262.954,265.951,270.451,273.007,278.506,284.005,287.002,292.006,298.009" svgx:width="0.33,0.5,0.33,0.25,0.72,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.72,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.44,0.5,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.25,0.28,0.44,0.39,0.28,0.25,0.5,0.5,0.25,0.39,0.67,0.72,0.33,0.56,0.28,0.33,0.44,0.28,0.28,0.33,0.5,0.25,0.61,0.61,0.33,0.56,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for Anti-JCV Antibodies. Laboratory test by JCV-Stratify ELISA </text>
   <text y="131.949" x="62.362,68.86,72.856,76.357,79.165,83.665,87.661,90.658,93.655,98.155,101.152,108.154,112.15,116.65,119.458,123.454,125.956,128.764,135.262,139.762,142.264,144.766,148.762,153.262,156.763,159.013,161.821,168.319,172.315,176.815,183.817,187.813,190.81,195.31,197.56,200.368,203.365,207.865,210.673,214.669,217.477,220.474,224.47,226.972,229.969,234.469,237.97,242.47,246.466,250.462,252.964,255.466,259.966,263.962,266.77,270.766,275.266,279.262,281.764,286.264,289.765,292.267,295.768,298.018" svgx:width="0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.44,0.28,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.39,0.25,0.25,0.72,0.44,0.5,0.78,0.44,0.33,0.5,0.25,0.25,0.33,0.5,0.25,0.44,0.25,0.33,0.44,0.28,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was performed at Unilabs, Denmark. In a retrospective analysis, </text>
   <text y="142.947" x="62.362,66.862,69.859,73.855,78.355,82.351,84.853,88.849,93.349,97.345,101.341,104.158,108.658,111.655,113.977,120.475,124.975,127.477,129.979,132.976,136.477,142.48,148.816,151.138,157.636,162.136,164.638,167.14,171.64,176.14,180.64,183.142,187.138,190.639,192.889,195.706,199.702,204.202,208.702,212.203,214.705,219.205,223.201,226.198,228.7,233.2,237.7,240.517,245.017,249.013,253.513,258.013,262.009,264.646,266.896,269.713,273.709,278.209,282.205,285.022,289.018,293.518,298.018" svgx:width="0.5,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.72,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.72,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.5,0.44,0.5,0.5,0.44,0.33,0.25,0.25,0.44,0.5,0.44,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">prevalence of Anti-JCV Antibodies, considering gender, age and </text>
   <text y="153.945" x="62.362,66.862,69.859,72.361,76.861,79.858,81.712,86.212,90.208,92.71,96.706,99.208,101.71,105.706,110.206,117.208,121.204,125.704,128.701,131.203,134.2,138.196,142.192,144.694,151.696,155.692,160.192,162.694,164.944,166.798,170.794,174.295,176.149,182.647,186.643,189.145,191.647,193.501,197.497,200.998,202.852,207.352,210.349,214.345,218.845,222.841,225.343,229.339,233.839,237.835,241.831,243.685,247.681,252.181,256.681,258.535,262.531,267.031,271.531,276.031,280.027,283.024,286.525,289.027,293.527,298.027" svgx:width="0.5,0.33,0.28,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.44,0.39,0.25,0.5,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">prior natalizumab-treatment, as well as prevalence and conversion </text>
   <text y="164.943" x="62.362,65.359,69.355,71.857,75.853,78.103,81.1,85.6,88.597,90.847,95.347,97.849,100.684,103.681,107.677,110.674,114.67,119.17,121.672,123.922,127.918,132.418,134.92,137.917,142.417,145.252,148.249,151.246,153.748,158.248,162.748,165.25,169.246,173.242,176.743,178.993,185.491,189.487,192.484,196.48,198.73,202.726,207.226,211.222,213.724,218.224,222.22,226.216,230.716" svgx:width="0.33,0.44,0.28,0.44,0.25,0.33,0.5,0.33,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.44,0.5,0.28,0.33,0.5,0.33,0.33,0.33,0.28,0.5,0.5,0.28,0.44,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rate for different cut-off-indices were analyzed.</text>
   <text y="175.941" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="175.941" x="98.506,106.642,109.144,111.646,116.146,118.396,121.294,123.796,128.296,132.292,134.542,137.44,141.436,145.432,147.934,152.434,156.43,158.932,161.182,164.08,168.076,172.576,175.078,178.075,182.575,185.41,188.407,191.404,193.906,198.406,202.906,206.902,211.402,213.652,216.55,221.05,224.047,226.297,229.195,233.695,235.945,240.445,243.442,247.942,250.192,254.692,256.942,259.192,262.09,266.59,271.09,273.34,277.84,285.337,287.587,290.485,294.985,297.982" svgx:width="0.94,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.33,0.5,0.33,0.33,0.33,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.25,0.5,0.33,0.5,0.25,0.5,0.25,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">With the actual cut-off-index of 0.2-0.4, 62.9% of </text>
   <text y="186.939" x="62.362,70.363,75.367,78.364,82.864,86.86,89.362,91.864,95.86,100.36,102.862,106.363,108.838,115.336,119.332,122.329,126.325,128.8,131.302,135.298,138.799,141.301,145.297,149.797,152.272,156.772,161.272,164.773,167.275,169.777,172.279,176.779,180.775,183.25,186.247,190.747,193.744,195.724,202.222,206.722,209.224,211.726,214.723,218.224,224.227,230.563,232.543,239.041,243.541,246.043,248.545,253.045,257.545,262.045,264.547,268.543,272.044,274.519,278.515,281.017,283.492,286.489,288.991,291.988,295.489,297.991" svgx:width="0.89,0.56,0.33,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.72,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.72,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.44,0.28,0.25,0.33,0.28,0.33,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS-patients were tested positive for Anti-JCV Antibodies at first </text>
   <text y="197.937" x="62.362,64.864,68.86,72.361,74.863,77.365,81.865,86.365,88.615,90.865,93.097,96.598,101.098,105.598,112.096,114.598,119.098,123.598,125.848,128.08,132.076,134.326,136.558,140.059,142.561,147.061,151.561,154.063,157.06,159.562,163.558,167.554,172.054,174.556,176.806,179.038,182.035,186.535,191.611,196.111,198.361,202.861,207.361,211.861,214.858,217.108,219.34,223.336,227.836,230.833,233.83,237.826,240.328,244.324,246.826,249.328,253.828,258.328,260.578,262.81,269.308,271.81,274.312,278.812,281.062,283.294,287.29,291.79,295.786,298.036" svgx:width="0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.39,0.5,0.5,0.72,0.28,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">testing, showing a significant (p=0.014) correlation with age. </text>
   <text y="208.935" x="62.362,67.861,72.361,76.357,79.354,83.35,85.798,92.296,96.292,99.793,102.241,105.238,109.738,114.238,118.738,123.238,125.686,129.682,132.13,134.632,137.629,141.625,146.125,150.625,153.073,156.07,160.57,163.567,166.015,170.515,173.017,177.517,182.017,186.013,189.01,191.458,195.958,198.955,202.951,207.451,211.447,213.949,217.945,222.445,226.441,230.437,232.885,235.387,239.887,242.335,249.337,253.333,255.835,259.831,262.279,265.276,269.776,274.276,276.526,281.026,288.523,290.971,293.473,297.973" svgx:width="0.61,0.5,0.44,0.33,0.44,0.25,0.72,0.44,0.39,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.44,0.25,0.28,0.33,0.44,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.5,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.25,0.78,0.44,0.28,0.44,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">There was found a trend for higher prevalence in male (61.7% in </text>
   <text y="219.933" x="62.362,65.359,69.355,76.357,80.353,82.855,86.851,88.66,93.16,96.661,98.911,100.72,105.22,109.72,111.97,116.47,123.967,125.776,128.278,132.778,134.587,141.589,145.585,148.087,152.083,155.08,157.33,159.139,165.637,170.137,174.133,177.13,181.126,185.122,188.623,190.432,194.932,198.928,201.43,205.426,207.928,210.43,214.426,218.926,225.928,229.924,234.424,237.421,239.923,242.92,246.916,250.912,253.414,260.416,264.412,268.912,271.414,273.223,277.723,280.225,284.725,286.534,291.034,295.534,298.036" svgx:width="0.33,0.44,0.78,0.44,0.28,0.44,0.25,0.5,0.39,0.25,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.28,0.5,0.25,0.78,0.44,0.28,0.44,0.33,0.25,0.25,0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">female vs. 66.7% in male), whereas natalizumab-treatment did not </text>
   <text y="230.931" x="62.362,65.863,70.363,74.863,81.361,83.728,87.724,92.224,96.724,99.091,103.087,105.922,108.919,112.915,116.911,119.413,121.78,126.28,130.78,132.652,139.15,143.65,146.152,148.654,151.651,155.152,161.155,167.491,169.363,175.861,180.361,182.863,185.365,189.865,194.365,198.865,203.365,205.732,208.234,212.734,217.234,221.23,225.73,227.98,230.347,235.351,239.851,242.848,245.215,249.211,253.711,256.213,259.21,263.71,266.545,269.542,272.539,275.041,279.541,284.041,286.543,290.539,294.535,298.036" svgx:width="0.39,0.5,0.5,0.72,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.72,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.72,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.56,0.5,0.33,0.25,0.44,0.5,0.28,0.33,0.5,0.33,0.33,0.33,0.28,0.5,0.5,0.28,0.44,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">show any effect on Anti-JCV Antibody index. For cut-off-indices </text>
   <text y="241.929" x="62.362,66.862,69.859,72.109,74.287,78.787,81.037,85.537,87.787,89.965,93.961,98.461,102.961,105.211,107.389,111.889,114.139,118.639,120.889,123.139,125.317,128.314,132.31,134.812,138.808,142.309,144.559,146.737,151.237,154.234,156.484,158.662,162.163,168.166,173.836,176.833,181.333,185.329,189.829,193.825,196.327,198.829,203.329,207.325,209.575,211.753,216.253,220.249,222.751,225.253,229.249,233.749,236.251,239.752,242.002,244.18,248.176,250.678,252.928,255.106,258.103,260.605,263.602,267.103,269.605,271.855,274.033,276.535,280.531,284.032,286.534,289.036,293.536,298.036" svgx:width="0.5,0.33,0.25,0.55,0.5,0.25,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.25,0.25,0.55,0.33,0.44,0.28,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.67,0.72,0.33,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.28,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.25,0.55,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of 0.9 and 1.5, rates of JCV-negative patients at first testing </text>
   <text y="252.927" x="62.362,64.864,69.364,73.36,76.357,80.353,84.349,87.85,91.846,96.346,99.046,101.548,106.048,108.748,113.248,117.748,119.998,124.498,127.198,131.194,135.694,140.194,142.894,147.394,151.894,154.144,158.644,166.141,168.391,171.091,174.088,178.084,181.585,186.085,190.081,194.077,196.579,199.081,203.581,207.577,210.079,213.994,216.244,218.944,223.948,228.448,231.445,234.145,236.647,241.147,245.143,248.644,252.64,255.34,259.84,262.342,266.842,271.342,275.338,278.335,281.035,283.537,288.037,292.537,295.039" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25,0.56,0.5,0.33,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increased to 52.5 and 62.2%, respectively. For these higher indi-</text>
   <text y="263.925" x="62.362,66.358,70.354,73.855,76.105,77.959,82.459,86.455,90.955,94.951,97.453,99.955,104.455,108.451,110.305,114.805,117.802,121.798,126.298,128.8,132.796,135.298,137.8,142.3,146.296,148.15,152.65,156.646,159.148,163.648,167.644,169.498,172.0,176.5,178.354,181.351,185.347,187.849,191.845,195.346,197.848,200.35,204.85,209.35,211.204,213.706,218.206,222.202,225.199,229.195,233.191,236.692,240.688,245.188,247.042,251.038,254.539,256.393,262.891,266.887,269.389,271.891,274.141,275.995,279.496,283.996,288.496,294.994" svgx:width="0.44,0.44,0.39,0.25,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.25,0.39,0.5,0.5,0.72,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ces, negative predictive value in retesting increased as well, show-</text>
   <text y="274.923" x="62.362,64.864,69.364,73.864,75.817,79.813,81.766,84.268,88.768,95.266,99.262,102.259,104.212,107.209,111.205,113.707,117.703,119.656,124.156,127.153,129.106,132.607,136.603,139.6,144.1,148.096,152.596,157.096,161.596,165.592,168.589,171.091,175.087,178.084,181.585,183.538,186.535,189.532,192.529,197.029,204.031,205.984,210.484,212.734,217.234,224.731,226.684,230.68,233.182,235.135,237.637,242.137,246.637,250.633,255.133,257.086,261.586,263.836,268.336,270.289,272.791,277.291,279.244,283.744,285.994,290.494,297.991" svgx:width="0.28,0.5,0.5,0.25,0.44,0.25,0.28,0.5,0.72,0.44,0.33,0.25,0.33,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.39,0.44,0.33,0.5,0.44,0.5,0.5,0.5,0.44,0.33,0.28,0.44,0.33,0.39,0.25,0.33,0.33,0.33,0.5,0.78,0.25,0.5,0.25,0.5,0.83,0.25,0.44,0.28,0.25,0.28,0.5,0.5,0.44,0.5,0.25,0.5,0.25,0.5,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.83,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing a lower rate of seroconverters (from 8.3% at index 0.4 to 2.8% </text>
   <text y="285.921" x="62.362,66.358,68.86,71.11,73.612,78.112,82.612,86.608,91.108,93.358,97.858,100.108,104.608,107.605" svgx:width="0.44,0.28,0.25,0.28,0.5,0.5,0.44,0.5,0.25,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">at index 1.5).</text>
   <text y="296.919" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="296.919" x="119.341,124.345,127.342,131.338,135.838,139.834,142.336,146.332,150.832,154.828,158.824,161.074,166.294,169.291,173.791,176.788,179.038,183.763,190.261,194.761,197.263,199.765,202.762,206.263,212.266,218.602,220.852,225.577,232.075,236.575,239.077,241.579,246.079,250.579,255.079,257.581,261.577,265.078,267.328,272.548,275.05,279.55,281.8,287.02,289.522,294.022,298.018" svgx:width="0.56,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.72,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.55,0.72,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Prevalence for Anti-JCV Antibodies in the </text>
   <text y="307.917" x="62.362,65.359,69.859,74.359,77.86,82.36,85.357,89.857,93.853,98.353,100.603,101.728,105.724,108.721,112.717,116.713,118.963,120.088,122.59,126.091,128.341,129.466,133.462,137.962,142.462,145.459,149.959,154.459,156.961,163.963,167.959,170.461,174.457,176.959,181.459,183.709,184.834,189.334,193.834,201.331,203.581,205.831,206.956,213.454,217.954,221.95,224.947,228.943,233.443,237.943,240.193,241.318,245.314,249.814,253.81,256.06,257.176,261.172,265.672,270.172,272.422,273.547,278.047,282.043,286.543,291.043,295.039,298.036" svgx:width="0.33,0.5,0.5,0.39,0.5,0.33,0.5,0.44,0.5,0.25,0.55,0.44,0.33,0.44,0.44,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.5,0.28,0.78,0.44,0.28,0.44,0.28,0.5,0.25,0.55,0.5,0.5,0.83,0.25,0.25,0.55,0.72,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Innsbruck area is approximately 63%, whereby age and gender </text>
   <text y="318.915" x="62.362,66.358,70.858,75.358,79.354,83.35,86.347,88.669,91.171,95.671,97.993,102.493,106.489,108.811,111.313,115.813,118.81,121.312,125.812,129.808,134.308,138.304,140.806,145.306,149.806,152.128,156.628,160.624,163.621,166.123,170.119,174.619,177.121,181.117,184.618,186.868,189.19,195.193,199.693,202.015,205.516,209.512,212.014,214.516,217.018,221.518,226.018,228.34,232.84,235.342,239.842,244.342,248.338,251.335,253.657,257.653,262.153,264.655,267.652,272.152,274.987,277.984,280.981,283.483,287.983,292.483,294.985" svgx:width="0.44,0.5,0.5,0.44,0.44,0.33,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.28,0.5,0.33,0.28,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.67,0.5,0.25,0.39,0.44,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.28,0.33,0.5,0.33,0.33,0.33,0.28,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">appear to be influencing variables. By setting higher cut-off-indi-</text>
   <text y="329.913" x="62.362,66.358,70.354,73.855,76.105,78.355,82.855,86.851,91.351,95.347,97.849,100.351,104.851,108.847,111.097,115.597,118.594,122.59,127.09,129.592,133.588,136.09,138.592,143.092,147.088,149.338,153.838,157.834,160.336,164.836,168.832,171.082,175.582,178.579,180.829,183.331,187.831,191.827,194.077,196.579,200.575,204.076,206.578,208.828,212.824,217.324,221.824,224.326,228.826,231.076,235.576,239.572,241.822,244.324,248.824,252.82,255.817,259.813,263.809,267.31,271.306,275.806" svgx:width="0.44,0.44,0.39,0.25,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.5,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.39,0.28,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ces, negative predictive value of the test could be increased.</text>
   <text y="356.913" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P887</text>
   <text y="367.911" x="62.362,65.863,69.364,71.614,74.611,79.615,83.611,87.607,91.603,93.853,98.353,103.357,105.607,108.109,113.113,117.109,121.105,125.101,129.601,133.102,137.098,142.102,144.352,148.348,152.848,157.852,161.848,165.844,169.84,172.09,176.086,178.588,182.089,187.093,189.343,191.845,196.849,199.099,204.103,208.099,212.599,217.603,220.105,224.101,226.351,232.849,235.351,238.348,243.352" svgx:width="0.39,0.39,0.25,0.33,0.56,0.44,0.44,0.44,0.25,0.5,0.56,0.25,0.28,0.56,0.44,0.44,0.44,0.5,0.39,0.44,0.56,0.25,0.44,0.5,0.56,0.44,0.44,0.44,0.25,0.44,0.28,0.39,0.56,0.25,0.28,0.56,0.25,0.56,0.44,0.5,0.56,0.28,0.44,0.25,0.72,0.28,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Is there an increased cancer risk in people with </text>
   <text y="378.909" x="62.362,66.358,70.354,72.856,77.356,82.36,85.861,88.363,93.367,97.867,100.117,107.614,112.618,115.12,118.117,120.619,125.623,128.125,132.121,134.371,137.872,141.868,144.37,148.366,152.362,156.862,160.363,162.865,166.366,168.616,171.613,176.113,181.117,183.619,188.623,193.123,195.373,199.369,201.871,206.371,211.375,215.371,217.873,222.877,225.379,230.383,234.379" svgx:width="0.44,0.44,0.28,0.5,0.56,0.39,0.28,0.56,0.5,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.33,0.5,0.56,0.28,0.56,0.5,0.25,0.44,0.28,0.5,0.56,0.44,0.28,0.56,0.28,0.56,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">relapsing multiple sclerosis taking cladribine?</text>
   <text y="389.907" x="62.362,65.863,68.113,73.117,77.113,81.613,86.113,90.613,95.113" svgx:width="0.39,0.25,0.56,0.44,0.5,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">J Pakpoor</text>
   <text y="387.439" x="98.11" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="389.959" x="101.035,103.285,105.535,112.033,114.283,120.781,123.283,126.784,130.78,135.28,137.782" svgx:width="0.25,0.25,0.72,0.25,0.72,0.28,0.39,0.44,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Disanto</text>
   <text y="387.439" x="142.281" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="389.959" x="145.206,147.456,149.706,156.204,162.208,164.458,170.956,173.458,175.96,182.962,186.958,191.458" svgx:width="0.25,0.25,0.72,0.67,0.25,0.72,0.28,0.28,0.78,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, DR Altmann</text>
   <text y="387.439" x="195.957" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="389.959" x="198.882,201.132,203.382,208.386,210.636,215.64,219.636,224.136,226.638,229.14" svgx:width="0.25,0.25,0.56,0.25,0.56,0.44,0.5,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Pavitt</text>
   <text y="387.439" x="231.642" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="389.959" x="234.567,236.817,239.067,245.07,247.32,252.819,257.319,260.316,264.816,268.812" svgx:width="0.25,0.25,0.67,0.25,0.61,0.5,0.33,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Turner</text>
   <text y="387.439" x="271.808,274.733,276.196" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2,5</text>
   <text y="389.959" x="279.121,281.371" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="400.957" x="62.365,70.366,72.616,78.619,82.615,85.117,89.113,93.613,98.113,101.11,109.111,113.107,116.104,118.606" svgx:width="0.89,0.25,0.67,0.44,0.28,0.44,0.5,0.5,0.33,0.89,0.44,0.33,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M Calado-Marta</text>
   <text y="398.439" x="122.598,125.523,126.986" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2,5</text>
   <text y="400.959" x="129.911,132.161,134.411,140.909,143.159,146.66,151.16,153.662,156.164,160.664,164.165,167.666,172.166" svgx:width="0.25,0.25,0.72,0.25,0.39,0.5,0.28,0.28,0.5,0.39,0.39,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Juliusson</text>
   <text y="398.439" x="176.665" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">6</text>
   <text y="400.959" x="179.59,181.84,184.09,190.589,192.839,198.842,202.838,207.338,211.334" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Baker</text>
   <text y="398.439" x="214.33" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="400.959" x="217.255,219.505,221.755,225.256,227.506,233.509,238.009,242.005,244.507,248.503,255.001,258.997" svgx:width="0.25,0.25,0.39,0.25,0.67,0.5,0.44,0.28,0.44,0.72,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Chataway</text>
   <text y="398.439" x="263.496" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">7</text>
   <text y="400.959" x="266.421,268.671,270.921,277.419" svgx:width="0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K </text>
   <text y="411.957" x="62.364,67.368,71.364,75.864,82.866,85.368,89.364,92.361,96.357" svgx:width="0.56,0.44,0.5,0.78,0.28,0.44,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Schmierer</text>
   <text y="409.439" x="99.352,102.277,103.739" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2,5</text>
   <text y="420.437" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="422.959" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,109.531,112.033,114.283,120.781,124.777,127.279,131.779,135.28,139.78,142.03,144.28,150.778,154.774,157.276,161.776,165.277,169.777,172.027,174.277,180.775,185.275,187.777,190.279,194.275,198.775,201.025,207.028,209.53,214.03,218.53,223.03,227.53,234.028,236.278" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.72,0.44,0.28,0.5,0.39,0.5,0.25,0.25,0.72,0.44,0.28,0.5,0.39,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Oxford, Oxford, United Kingdom, </text>
   <text y="420.439" x="238.526" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="422.959" x="241.451,247.949,252.449,256.445,260.441,264.941,267.191,274.688,279.188,282.689,286.685" svgx:width="0.72,0.5,0.44,0.44,0.5,0.25,0.83,0.5,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Queen Mary </text>
   <text y="433.957" x="62.36,68.858,73.358,75.86,79.856,83.852,87.353,90.854,93.356,95.858,99.854,102.104,106.604,109.106,111.356,116.36,120.86,125.36,129.86,134.36,138.86,141.11,143.36,148.859,153.359,156.86,159.362,162.863,165.113,169.613,174.113,178.613,180.863,183.365,187.865,191.861,194.111,199.115,203.615,208.115,212.615,217.115,221.615,223.865,228.365,232.361,236.861,241.361,245.861,248.363,250.613,255.113,257.615,259.865,267.362,271.358,275.858,278.36,282.356,284.858,289.358,293.354" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.25,0.61,0.5,0.39,0.28,0.39,0.25,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.5,0.28,0.25,0.83,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of London, Barts and the London School of Medicine </text>
   <text y="444.955" x="62.36,66.86,71.36,75.86,78.11,84.608,88.604,93.104,95.606,98.108,101.609,104.111,107.612,111.608,113.858,116.108,121.607,124.109,126.611,130.112,134.612,138.113,142.613,144.863,147.86,152.36,155.861,158.363,160.865,163.367,167.867,170.369,174.365,176.615,178.865,183.869,188.369,192.869,197.369,201.869,206.369,208.619,210.869,217.367,221.867,224.369,226.871,230.867,235.367,237.617,243.62,246.122,250.622,255.122,259.622,264.122,270.62,272.87" svgx:width="0.5,0.5,0.5,0.25,0.72,0.44,0.5,0.28,0.28,0.39,0.28,0.39,0.44,0.25,0.25,0.61,0.28,0.28,0.39,0.5,0.39,0.5,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">and Dentistry, Blizard Institute, London, United Kingdom, </text>
   <text y="453.439" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="455.959" x="65.287,70.291,74.791,79.291,83.791,88.291,92.791,95.041,99.541,103.537,108.037,112.537,117.037,119.539,121.789,126.289,128.791,131.041,137.539,141.535,146.035,148.537,152.533,157.033,161.029,163.279,167.779,172.279,176.779,179.029,184.033,187.534,192.034,196.534,199.036,203.032,207.532,210.034,212.284,219.781,223.777,228.277,230.779,234.775,237.277,241.777,245.773,248.023,250.273,255.277,259.777,264.277,268.777,273.277,277.777,280.027" svgx:width="0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.5,0.28,0.25,0.72,0.44,0.5,0.28,0.44,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.56,0.39,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.83,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">London School of Hygiene and Tropical Medicine, London, </text>
   <text y="466.957" x="62.362,68.86,73.36,75.862,78.364,82.36,86.86,89.11,95.113,97.615,102.115,106.615,111.115,115.615,122.113,124.363" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United Kingdom, </text>
   <text y="464.439" x="126.613" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="466.959" x="129.538,136.036,140.536,143.038,147.034,151.03,154.531,158.032,160.534,163.036,167.032,169.282,173.782,176.284,178.534,183.538,187.534,191.53,196.03,199.531,201.781,204.031,210.034,214.03,218.53,221.032,225.028,228.529,230.779,233.281,237.781,241.282,243.532,250.03,254.026,258.526,261.028,263.53,268.03" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.56,0.44,0.44,0.5,0.39,0.25,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.39,0.25,0.72,0.44,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Leeds, Center for Health </text>
   <text y="477.957" x="62.362,66.862,70.858,74.359,78.355,80.857,84.853,88.849,92.35,94.6,100.099,104.095,107.596,111.592,116.092,119.593,123.589,128.089,130.339,132.589,137.593,141.589,145.585,150.085,153.586,155.836,158.086,164.584,169.084,171.586,174.088,178.084,182.584,184.834,190.837,193.339,197.839,202.339,206.839,211.339,217.837,220.087" svgx:width="0.5,0.44,0.39,0.44,0.28,0.44,0.44,0.39,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.25,0.56,0.44,0.44,0.5,0.39,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Services Research, Leeds, United Kingdom, </text>
   <text y="475.439" x="222.335" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">5</text>
   <text y="477.959" x="225.26,230.759,235.259,238.76,241.262,244.763,247.013,253.511,257.507,262.007,264.509,267.011,271.511,273.761,279.764,286.262,290.762" svgx:width="0.61,0.5,0.39,0.28,0.39,0.25,0.72,0.44,0.5,0.28,0.28,0.5,0.25,0.67,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Barts Health NHS </text>
   <text y="488.957" x="62.36,67.364,70.865,75.365,78.866,81.368,83.618,85.868,90.872,95.372,99.368,101.618,107.117,111.617,115.613,120.113,122.615,124.865,129.869,134.369,138.869,143.369,147.869,152.369,154.619,161.117,165.617,169.118,173.618,176.12,178.622,183.122,185.624,187.874,190.124,196.622,200.618,205.118,209.618,213.119,215.621,222.119,226.115,230.615,233.117,235.367,239.867,242.369,244.619,250.622,254.618,259.118,262.619,267.119,269.621,274.121,278.621,282.617,284.867" svgx:width="0.56,0.39,0.5,0.39,0.28,0.25,0.25,0.56,0.5,0.44,0.25,0.61,0.5,0.44,0.5,0.28,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Trust, The Royal London Hospital, Department of Neurology, </text>
   <text y="499.955" x="62.36,67.364,71.864,76.364,80.864,85.364,89.864,92.114,94.364,100.862,105.362,107.864,110.366,114.362,118.862,121.112,127.115,129.617,134.117,138.617,143.117,147.617,154.115,156.365" svgx:width="0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">London, United Kingdom, </text>
   <text y="497.439" x="158.617" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">6</text>
   <text y="499.959" x="161.542,166.546,171.046,175.546,180.046,182.296,188.794,193.294,195.796,199.792,203.788,207.289,210.79,213.292,215.794,219.79,222.04,224.29,229.294,233.794,238.294,242.794,245.044,247.294,251.794,257.797,261.793,266.293,270.289,274.789,277.039" svgx:width="0.56,0.5,0.5,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.56,0.5,0.5,0.5,0.25,0.25,0.5,0.67,0.44,0.5,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Lund University, Lund, Sweden, </text>
   <text y="508.439" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">7</text>
   <text y="510.959" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,111.034,115.534,118.036,120.538,124.534,129.034,133.03,135.28,140.284,144.784,149.284,153.784,158.284,162.784,165.034,171.532,176.032,179.533,184.033,186.535,189.037,193.537,196.039,199.54,201.79,207.793,214.291,218.791,221.041,226.54,231.04,235.54,240.04,244.54,249.04,251.542,254.044,258.544,263.044,265.294,270.298,273.799,278.299,281.8,284.302,286.552" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.67,0.5,0.28,0.28,0.44,0.5,0.44,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.39,0.25,0.67,0.72,0.5,0.25,0.61,0.5,0.5,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.56,0.39,0.5,0.39,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University College London Hospitals NHS Foundation Trust, </text>
   <text y="521.957" x="62.362,67.366,71.866,75.862,78.094,84.097,88.597,91.099,93.601,98.101,102.601,107.101,109.603,111.835,118.333,122.833,126.334,130.834,133.336,135.838,140.338,142.84,145.072,147.574,152.074,155.575,157.807,163.81,167.806,172.306,175.807,180.307,182.809,187.309,191.809,195.805,198.037,202.537,207.037,211.537,213.769,219.772,223.768,228.268,231.769,236.269,239.77,244.27,247.771,252.271,256.267,259.768,263.764,266.014,268.246,273.25,277.75,282.25,286.75,291.25,295.75,298.0" svgx:width="0.56,0.5,0.44,0.25,0.67,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.28,0.5,0.39,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.5,0.39,0.5,0.44,0.39,0.44,0.25,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">The National Hospital for Neurology and Neurosurgery, London, </text>
   <text y="532.955" x="62.362,68.86,73.36,75.862,78.364,82.36,86.86,89.11,95.113,97.615,102.115,106.615,111.115,115.615" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United Kingdom</text>
   <text y="559.955" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="559.955" x="115.264,121.267,123.823,126.325,130.321,133.156,137.656,141.652,144.208,148.708,153.208,157.204,160.705,164.701,167.257,170.254,173.251,176.248,178.804,181.306,184.303,186.805,190.801,193.303,195.859,198.856,204.859,210.358,216.856,222.859,225.856,231.355,237.853,240.85,243.406,247.906,250.903,253.459,257.959,260.956,264.952,267.454,270.01,274.006,276.508,280.504,285.004,288.001,290.503,295.003" svgx:width="0.72,0.25,0.28,0.44,0.33,0.5,0.44,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.33,0.33,0.33,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.33,0.67,0.61,0.72,0.67,0.33,0.61,0.72,0.33,0.25,0.5,0.33,0.25,0.5,0.33,0.44,0.28,0.25,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A large phase III trial (CLARITY) of oral cladrib-</text>
   <text y="570.953" x="62.362,64.864,69.364,73.36,75.61,79.453,82.45,90.451,94.951,99.451,103.447,107.443,109.945,112.942,117.442,120.439,122.689,126.532,129.034,133.534,135.784,139.627,144.127,148.123,152.623,157.123,159.625,163.621,165.871,169.714,176.212,178.714,181.216,185.716,187.966,191.809,194.806,198.802,201.304,205.3,209.8,213.301,215.803,220.303,224.803,227.053,230.896,237.898,242.398,244.9,247.402,249.904,254.404,256.906,260.902,263.152,266.995,270.496,274.492,276.994,280.99,283.987,288.487,291.988,294.49,297.991" svgx:width="0.28,0.5,0.44,0.25,0.55,0.33,0.89,0.5,0.5,0.44,0.44,0.28,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.5,0.28,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ine (Movectro) in people with relapsing multiple sclerosis </text>
   <text y="581.951" x="62.362,65.359,69.859,76.357,82.36,90.361,95.365,98.362,100.612,101.413,104.41,108.406,112.906,117.406,120.403,122.905,126.901,131.401,133.651,134.452,137.953,140.455,144.955,149.455,151.957,154.954,157.456,161.452,165.448,169.948,172.45,174.7,175.501,179.497,182.332,185.329,187.831,191.827,195.823,199.819,203.734,205.984,208.234,209.044,215.542,220.042,226.54,230.536,235.036,239.032,241.669,243.919,246.169,246.97,250.966,255.466,259.966,263.962,267.958,270.955,275.455,278.956,281.206,282.007,286.507,291.007,295.003,298.0" svgx:width="0.33,0.5,0.72,0.67,0.89,0.56,0.33,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.25,0.55,0.72,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.44,0.44,0.33,0.5,0.39,0.25,0.55,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(pwRMS) reported significant efficacy. However, concerns over </text>
   <text y="592.949" x="62.362,64.864,69.364,73.36,75.61,78.607,82.108,86.104,89.101,93.097,95.599,100.099,102.349,105.346,109.846,112.843,115.093,118.09,122.086,124.588,128.584,133.084,136.081,138.583,143.083,145.585,150.085,154.081,156.331,159.328,163.828,167.824,172.324,176.32,178.57,181.567,186.067,190.063,194.059,198.559,200.809,203.806,206.803,210.799,213.301,216.802,220.798,225.298,227.548,230.545,235.045,239.545,241.795,244.297,250.795,257.797,261.793,264.79,267.292,271.288,275.284,279.784,282.034,285.031,289.027,293.527,298.027" svgx:width="0.28,0.5,0.44,0.25,0.55,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.5,0.44,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.78,0.44,0.33,0.28,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the safety of cladribine have been raised by American and </text>
   <text y="603.947" x="62.362,67.861,72.361,75.358,79.858,84.358,88.354,92.35,96.85,99.1,100.315,103.312,107.308,111.808,116.308,118.81,122.806,125.308,129.808,132.805,137.305,139.555,140.77,145.27,149.77,154.27,156.772,160.768,164.269,166.519,168.769,169.984,174.988,179.488,183.484,187.48,189.982,192.979,195.481,199.477,203.473,205.975,208.477,212.392,214.642,216.892,218.107,222.103,224.353,225.568,229.069,233.569,237.07,241.57,245.566,249.562,252.064,256.06,260.56,262.81,264.025,266.527,271.027,275.023,278.02,282.016,286.012,289.513,293.509,298.009" svgx:width="0.61,0.5,0.33,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.56,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.44,0.25,0.55,0.39,0.5,0.39,0.5,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">European regulatory bodies. Specifically, a suspected increased </text>
   <text y="614.945" x="62.362,66.358,70.354,74.854,78.85,82.846,85.843,88.183,91.18,93.682,97.183,101.683,104.023,110.521,114.517,118.018,120.358,124.858,128.854,133.354,135.694,138.691,143.191,146.188,148.528,151.03,155.53,159.526,161.866,164.863,168.859,171.361,175.357,179.353,181.855,184.357,188.857,193.357,195.697,200.197,203.194,205.534,209.53,212.032,216.028,220.528,223.525,226.027,230.527,233.029,237.529,241.525,243.865,246.862,251.362,254.359,256.699,261.199,267.697,273.7,281.701,286.705,289.045,293.545,298.045" svgx:width="0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.33,0.28,0.39,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.5,0.72,0.67,0.89,0.56,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cancer risk was key for the rejection of cladribine for pwRMS by </text>
   <text y="625.943" x="62.362,64.864,69.364,73.36,75.574,81.073,85.573,88.57,93.07,97.57,101.566,105.562,110.062,112.276,120.277,124.273,128.773,131.275,135.271,137.773,142.273,146.269,149.77,151.489,157.987,162.487,166.483,170.983,174.979,179.479,181.693,184.69,190.189,198.19,204.688,207.685,209.899,212.401,216.901,219.115,223.615,228.115,232.282,236.782,239.032,241.084,246.583,251.083,255.079,257.293,260.794,267.796,271.792,274.294,276.796,279.01,283.51,288.01,295.012" svgx:width="0.28,0.5,0.44,0.25,0.61,0.5,0.33,0.5,0.5,0.44,0.44,0.5,0.25,0.89,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.39,0.25,0.72,0.5,0.44,0.5,0.44,0.5,0.25,0.33,0.61,0.89,0.72,0.33,0.25,0.28,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.39,0.78,0.44,0.28,0.28,0.25,0.5,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the European Medicines Agency (EMA) in 2011. The small num-</text>
   <text y="636.941" x="62.362,66.862,70.858,73.855,76.105,76.825,81.325,84.322,86.572,87.292,91.792,96.292,99.793,103.789,106.786,111.286,115.282,119.782,122.032,122.752,126.748,130.744,135.244,139.24,143.236,146.233,148.483,149.203,153.703,158.203,161.2,163.702,168.202,172.702,174.952,175.672,181.675,187.174,193.672,199.675,202.672,208.171,214.336,216.586,217.306,224.308,228.304,232.804,235.054,235.774,240.274,244.27,246.52,247.24,249.742,254.242,257.743,262.243,265.078,268.075,270.577,274.573,277.075,281.071,285.571,288.073,290.323,291.043,293.545,298.045" svgx:width="0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.67,0.61,0.72,0.67,0.33,0.61,0.72,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.5,0.44,0.25,0.55,0.28,0.5,0.39,0.5,0.33,0.33,0.28,0.44,0.28,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ber of observed cancer during CLARITY may be insufficient to </text>
   <text y="647.939" x="62.362,66.862,70.858,73.855,76.357,80.857,83.359,85.861,88.363,92.863,96.859,99.361,103.861,106.111,110.107,113.608,117.109,121.105,124.606,128.107,130.357,134.353,138.349,142.849,146.845,150.841,153.838,156.088,159.085,161.587,165.088,169.588" svgx:width="0.5,0.44,0.33,0.28,0.5,0.28,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.33,0.28,0.39,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">definitively assess cancer risk.</text>
   <text y="658.937" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="658.937" x="111.655,119.431,123.427,125.677,129.232,133.228,137.728,144.73,149.23,153.226,156.223,160.219,164.719,166.969,170.524,173.026,177.526,181.522,183.772,187.327,191.323,195.319,199.819,203.815,207.811,210.808,213.058,216.613,219.61,222.112,225.613,230.113,232.363,235.918,240.418,243.415,245.665,249.22,253.216,255.718,259.714,264.214,267.211,269.713,274.213,276.715,281.215,285.211,287.461,291.016,293.518,298.018" svgx:width="0.94,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We compared the cancer risk of cladribine in </text>
   <text y="669.935" x="62.362,68.365,73.864,80.362,86.365,89.362,94.861,101.026,103.276,104.05,110.548,113.05,115.552,120.052,122.302,123.076,127.576,130.078,134.578,138.574,141.571,143.821,144.595,149.095,151.597,155.098,159.094,163.09,166.591,170.587,173.584,180.586,185.086,189.586,192.088,195.085,199.585,202.087,206.587,211.087,213.337,214.111,216.613,221.113,225.109,228.106,232.102,236.602,239.104,243.1,246.601,248.851,249.625,252.622,259.12,267.121,271.99,275.491,278.488,280.738,281.512,286.012,289.513,293.509,298.009" svgx:width="0.67,0.61,0.72,0.67,0.33,0.61,0.72,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.33,0.78,0.5,0.5,0.28,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.33,0.72,0.89,0.61,0.39,0.33,0.25,0.55,0.5,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CLARITY with other disease-modifying therapies (DMTs) used </text>
   <text y="680.933" x="62.362,64.864,69.364,71.614,74.116,78.616,82.612,84.862,87.364,90.361,94.357,98.353,100.855,107.857,111.853,116.353,118.855,121.105,125.605,128.602,130.852,135.352,141.85,147.853,155.854,160.858" svgx:width="0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.5,0.72,0.67,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in the treatment of pwRMS.</text>
   <text y="691.931" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="691.931" x="100.693,107.191,109.693,112.195,114.031,118.531,123.031,127.027,130.528,134.524,136.36,139.357,142.354,145.351,147.187,149.689,152.686,155.188,159.184,161.686,165.187,167.023,171.523,174.52,176.356,180.352,184.852,189.352,192.349,196.849,201.349,205.345,209.845,211.681,218.179,226.18,231.049,234.55,236.386,239.383,243.883,246.88,248.716,253.216,259.714,265.717,273.718,278.722,280.558,287.056,291.052,294.049,298.045" svgx:width="0.72,0.28,0.28,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.33,0.33,0.33,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.72,0.89,0.61,0.39,0.25,0.33,0.5,0.33,0.25,0.5,0.72,0.67,0.89,0.56,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">All phase III trials of approved DMTs for pwRMS were </text>
   <text y="702.929" x="62.362,64.864,69.364,73.36,75.862,80.362,84.862,88.858,93.358,95.608,97.858,102.862,105.364,108.865,113.365,117.361,120.358,123.355,126.856,129.106,133.102,137.602,141.598,145.594,148.096,150.346,152.848,156.844,160.345,162.847,165.097,171.595,175.591,179.092,181.342,185.842,189.343,193.339,197.839,200.089,202.591,207.091,209.341,213.337,217.837,224.839,229.339,233.335,236.332,240.328,242.578,246.574,250.57,255.07,259.066,263.062,266.059,268.309,271.306,275.302,277.804,281.8,285.301" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.56,0.28,0.39,0.5,0.44,0.33,0.33,0.39,0.25,0.44,0.5,0.44,0.44,0.28,0.25,0.28,0.44,0.39,0.28,0.25,0.72,0.44,0.39,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.25,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.33,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">included. FisherÂ´s exact test was used to compare cancer rates.</text>
   <text y="713.927" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="713.927" x="96.679,101.548,108.046,112.042,114.544,119.044,123.04,125.29,126.361,130.861,135.361,139.357,142.858,146.854,149.104,150.175,153.172,156.169,159.166,161.416,162.487,164.989,167.986,170.488,174.484,176.986,180.487,182.737,183.808,186.805,190.801,195.301,199.801,202.798,205.3,209.296,213.796,216.046,217.117,221.113,225.109,229.609,233.605,237.601,240.598,242.848,243.919,246.916,250.912,253.414,257.41,260.911,263.161,264.232,268.228,272.728,277.228,279.478,280.549,287.047,291.043,294.04,298.036" svgx:width="0.61,0.72,0.44,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.33,0.33,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Twelve phase III trials reported cancer rates and were </text>
   <text y="724.925" x="62.362,64.864,69.364,73.36,76.357,80.353,83.35,87.85,90.847,94.843,97.192,99.694,104.194,108.19,110.692,115.192,119.692,123.688,128.188,130.537,133.039,137.539,139.888,142.39,146.89,149.392,152.893,155.242,162.244,166.24,168.742,172.738,175.735,179.731,184.231,188.227,190.729,195.229,198.73,201.232,204.733,206.983,209.332,214.336,216.838,221.338,225.838,230.338,232.687,237.187,241.183,243.685,247.681,250.678,255.178,259.678,263.674,268.174,272.17,274.672,277.174,281.674,284.023,290.521,294.517,298.018" svgx:width="0.28,0.5,0.44,0.33,0.44,0.33,0.5,0.33,0.44,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.78,0.44,0.28,0.44,0.33,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.56,0.28,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">therefore included in this meta-analysis. Study heterogeneity was </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M360.180 402.300 L392.420 402.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,314.516,319.016,321.518,323.768,324.452,327.953,330.455,334.955,339.455,341.957,344.954,347.456,351.452,355.448,359.948,362.45,364.7,366.95,367.634,370.631,375.131,379.631,383.627,387.128,389.63,392.132,396.632,400.628,403.13,407.126,411.626,413.876,414.56,417.062,420.059,424.055,428.051,430.553,437.555,441.551,446.051,448.553,452.054,454.304,454.979,457.481,461.981,464.231,464.915,467.417,471.917,475.913,479.414,483.41,485.66,486.344,488.846,491.843,494.345,498.341,500.843,504.344,506.594,507.278,513.776,517.772,520.769,524.765,527.015,527.69,531.686,534.188,538.184,542.684" svgx:width="0.5,0.5,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.25,0.55,0.33,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">not significant. Investigated treatments in these trials were clad-</text>
   <text y="88.101" x="310.016,313.013,315.515,320.015,322.517,327.017,331.013,333.263,335.513,339.194,343.694,346.196,353.198,357.194,359.696,364.196,368.696,371.198,373.448,377.129,380.126,384.626,391.628,395.624,398.621,402.617,405.119,409.115,411.365,413.615,417.296,420.293,422.795,427.295,431.795,436.295,438.797,441.299,448.301,452.801,457.301,459.551,461.801,465.482,467.984,471.98,474.977,477.479,480.476,482.978,487.478,491.978,496.478,503.48,505.982,510.482,514.478,516.728,518.978,522.659,527.159,531.155,533.657,537.653,540.155,542.657" svgx:width="0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.25,0.55,0.5,0.28,0.78,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.33,0.5,0.78,0.44,0.33,0.44,0.28,0.44,0.25,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.55,0.28,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.25,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ribine, dimethyl fumarate, fingolimod, teriflunomide, natali-</text>
   <text y="99.099" x="310.016,314.012,318.512,325.514,329.51,334.01,336.26,338.51,339.743,343.739,346.241,350.237,357.239,359.741,364.241,368.237,372.737,379.739,383.735,388.235,390.485,391.718,395.714,400.214,404.714,406.964,408.197,412.697,415.199,419.195,421.697,424.199,427.196,431.192,438.194,442.19,445.187,447.437,448.67,452.666,456.662,460.658,463.16,467.156,469.658,473.654,475.904,478.154,479.225,484.724,489.224,493.22,495.47,496.703,500.204,504.2,508.7,512.696,517.196,519.446,520.679,524.18,526.682,531.182,535.682,538.184,542.18,545.681" svgx:width="0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.28,0.28,0.33,0.44,0.78,0.44,0.33,0.25,0.55,0.44,0.44,0.44,0.28,0.44,0.28,0.44,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.39,0.44,0.5,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab, alemtuzumab and glatiramer acetate. The seven studies </text>
   <text y="110.097" x="310.016,314.012,318.512,325.514,330.014,334.01,337.007,339.509,344.009,348.509,350.759,352.253,354.755,357.752,361.748,365.744,368.246,375.248,379.244,383.744,386.246,388.496,389.99,394.49,398.486,401.483,404.984,409.484,412.985,415.235,416.729,421.229,423.731,427.727,431.723,435.719,440.219,444.719,446.969,448.463,451.46,455.456,458.957,461.207,462.701,467.201,471.701,476.201,480.701,484.202,488.198,492.698,494.948,496.442,498.944,503.444,505.694,507.188,509.69,514.19,516.692,520.688,523.685,526.682,530.678,533.675,538.175,542.675" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.44,0.33,0.39,0.5,0.39,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.39,0.25,0.55,0.5,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">comparing treatment versus placebo (as opposed to interferon-</text>
   <text y="121.095" x="310.016,314.516,318.512,321.014,325.01,327.125,331.625,335.621,337.736,340.733,343.73,348.734,355.232,357.347,361.847,365.843,368.345,372.341,375.338,379.838,383.834,386.831,389.828,391.943,398.441,402.437,405.434,409.43,411.545,414.047,418.547,421.049,423.551,426.053,430.049,432.551,435.053,439.553,441.668,446.168,449.669,453.665,458.165,460.28,463.277,467.777,470.774,472.889,476.885,481.385,485.381,487.883,492.383,495.884,498.386,501.887,504.137,506.09,511.589,516.089,520.085,522.2,526.196,530.192,534.692,538.688,542.684,545.681" svgx:width="0.5,0.44,0.28,0.44,0.25,0.5,0.44,0.25,0.33,0.33,0.56,0.72,0.25,0.5,0.44,0.28,0.44,0.33,0.5,0.44,0.33,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.5,0.39,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.44,0.5,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">beta 1a (IFN beta-1a)) were initially used for analysis. The cancer </text>
   <text y="132.093" x="310.016,313.013,317.009,319.511,323.507,325.928,328.43,332.93,335.351,337.853,342.353,346.349,348.77,354.773,360.272,366.77,372.773,375.77,381.269,387.434,389.855,392.357,395.354,399.35,403.346,405.848,412.85,416.846,421.346,423.848,426.269,430.769,433.766,438.266,442.766,447.266,449.687,452.684,457.184,459.434,463.934,468.434,475.931,478.928,481.349,487.847,491.843,495.344,497.765,502.265,506.765,509.267,511.688,514.19,518.69,522.686,525.683,529.679,533.675,537.176,541.172,545.672" svgx:width="0.33,0.44,0.28,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.67,0.61,0.72,0.67,0.33,0.61,0.72,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.33,0.5,0.25,0.5,0.5,0.83,0.33,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rate in the CLARITY treatment group (1.13%) was not increased </text>
   <text y="143.091" x="310.016,314.012,318.512,325.514,330.014,334.01,337.007,341.003,345.503,347.753,348.995,351.497,355.997,358.247,359.489,363.485,365.987,368.489,370.739,371.981,376.481,378.983,383.483,387.479,390.476,392.726,393.968,396.47,399.467,403.463,407.459,409.961,416.963,420.959,425.459,427.961,430.211,431.453,435.953,438.95,443.45,447.95,452.45,455.951,458.201,460.451,461.693,468.191,472.691,476.687,479.189,483.689,487.685,490.682,492.932,494.174,496.676,501.176,505.172,507.674,512.174,516.674,519.176,523.676,528.176,530.426,531.668,536.168,538.67,542.666" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.28,0.28,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.25,0.55,0.72,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">compared to all other treatment groups, whether including pla-</text>
   <text y="154.089" x="310.016,314.012,318.008,322.508,327.008,329.114,333.11,337.61,342.11,344.612,347.609,352.109,354.611,357.113,361.109,365.609,367.715,370.217,373.214,375.716,379.712,382.214,385.715,387.821,392.321,396.821,399.323,403.823,405.929,408.926,413.426,415.676,420.176,427.673,429.923,432.029,436.529,441.605,443.711,448.211,450.461,454.628,459.128,463.628,468.128,471.125,473.231,477.731,480.728,482.834,486.83,489.332,491.834,493.94,498.44,500.942,505.442,509.438,512.435,514.541,517.043,520.04,522.542,526.538,529.04,532.541,534.791,536.897,539.399,543.395,545.645" svgx:width="0.44,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.5,0.5,0.28,0.5,0.25,0.33,0.5,0.25,0.5,0.83,0.25,0.25,0.5,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.5,0.33,0.25,0.44,0.28,0.28,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.25,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cebo controlled trials only (0.6%, p= 0.1139) or all other trials, ie. </text>
   <text y="165.087" x="310.016,312.518,317.018,321.014,323.516,328.016,332.516,335.018,339.518,344.018,346.268,348.23,350.732,355.232,359.732,363.233,367.229,369.479,371.441,377.939,380.441,382.943,387.443,389.693,391.655,395.651,400.151,402.401,404.363,407.36,412.364,418.862,421.112,423.074,427.574,431.57,434.072,438.068,441.065,445.565,449.561,451.811,453.773,457.769,462.269,469.271,473.771,477.767,480.764,484.76,487.262,491.762,494.759,497.009,498.971,502.967,505.964,512.966,515.216,517.178,520.175,524.675,526.925,531.425,535.925,543.422,545.672" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.39,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.25,0.55,0.33,0.56,0.72,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.5,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.28,0.5,0.33,0.25,0.55,0.44,0.33,0.78,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.83,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">including those with an IFN beta-1a comparator arm (1.05%, </text>
   <text y="176.085" x="310.016,314.516,319.592,324.092,326.342,330.842,335.342,339.842,344.342,347.339,349.589,351.839,352.766,359.264,363.764,366.014,366.941,370.937,374.933,379.433,383.429,387.425,390.422,392.672,393.599,400.097,404.093,407.594,409.844,410.771,415.271,419.267,421.769,425.765,429.761,432.263,436.259,440.759,443.009,443.936,446.438,450.938,453.188,454.115,458.615,465.113,471.116,479.117,484.121,486.371,487.298,491.294,494.795,498.296,500.798,505.298,509.798,513.794,518.294,520.544,521.471,523.973,528.473,530.723,531.65,536.15,538.652,542.648" svgx:width="0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.5,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.72,0.67,0.89,0.56,0.25,0.55,0.44,0.39,0.39,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">p=0.0951). No cancer was detected in pwRMS assigned to pla-</text>
   <text y="187.083" x="310.016,314.012,318.008,322.508,327.008,329.258,330.257,332.759,337.259,339.509,340.508,346.511,352.01,358.508,364.511,367.508,373.007,379.172,381.422,382.421,388.919,393.419,395.921,398.423,401.924,404.426,406.676,407.675,410.177,414.677,418.673,420.923,421.922,425.918,430.418,437.42,441.92,444.422,448.922,452.918,457.418,459.668,460.667,464.663,468.659,473.159,477.155,481.151,484.148,486.398,487.397,490.394,494.39,496.892,500.888,503.138,504.137,508.637,511.634,513.884,514.883,518.879,521.381,523.883,526.133,527.132,531.632,534.134,538.634,542.63,545.627" svgx:width="0.44,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.61,0.72,0.67,0.33,0.61,0.72,0.25,0.55,0.72,0.5,0.28,0.28,0.39,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.28,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cebo in CLARITY whilst the combined cancer rate of all other </text>
   <text y="198.081" x="310.016,314.516,317.018,321.014,325.01,329.006,333.506,338.006,340.256,344.756,347.753,352.253,356.753,361.253,364.754,367.004,373.502,377.498,380.999,383.249,387.749,389.999,394.499,398.999,406.496,408.746,411.743,416.243,421.319,425.819,428.069,432.569,437.069,441.569,446.069,449.066" svgx:width="0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.5,0.5,0.83,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">placebo groups was 1.19% (p=0.0159).</text>
   <text y="209.079" x="322.013,327.512,332.012,336.008,338.15,342.146,346.142,350.642,354.638,358.634,361.631,363.773,366.77,370.766,373.268,377.264,379.406,383.906,386.903,389.045,393.041,397.037,400.034,404.534,406.676,409.178,413.678,415.82,418.322,422.822,426.818,428.96,434.963,440.462,446.96,452.963,455.96,461.459,467.624,469.766,474.266,476.768,480.764,484.76,488.756,493.256,497.756,499.898,504.398,507.395,511.895,516.395,520.895,523.037,525.539,529.04,531.182,535.178,537.68,541.181,545.681" svgx:width="0.61,0.5,0.44,0.25,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.33,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.44,0.44,0.33,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.67,0.61,0.72,0.67,0.33,0.61,0.72,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.28,0.39,0.25,0.44,0.28,0.39,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The cancer rate of zero in the CLARITY placebo group is also </text>
   <text y="220.077" x="310.016,312.518,317.018,323.516,327.512,330.509,333.074,335.576,340.076,344.072,348.572,351.137,353.639,358.139,360.704,363.206,367.706,371.702,374.267,377.264,381.26,385.256,389.252,393.752,396.254,398.756,403.256,405.821,408.818,412.814,417.314,421.814,424.811,427.313,431.309,435.809,438.374,442.874,447.374,451.37,454.871,458.867,461.432,464.429,467.426,470.423,472.988,475.49,478.487,480.989,484.985,487.487,490.052,494.552,497.549,500.114,504.11,506.612,510.608,515.108,518.105,520.607,525.107,527.609,532.109,536.105,538.67,541.172,545.672" svgx:width="0.28,0.5,0.72,0.44,0.33,0.25,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.33,0.33,0.33,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lower than in the recently reported phase III trial of cladribine in </text>
   <text y="231.075" x="310.016,314.516,318.512,323.012,327.512,330.014,334.01,335.819,342.317,344.819,347.321,351.821,353.63,357.626,360.128,362.63,367.13,369.632,373.628,377.624,380.126,382.628,387.128,388.937,391.439,394.94,399.44,401.942,405.938,408.44,412.436,416.936,418.745,422.246,426.746,431.246,435.746,438.743,443.243,450.245,454.241,456.05,459.551,464.051,468.551,473.051,477.047,480.548,483.05,485.552,490.052,494.048,495.857,500.357,503.354,505.163,509.663,513.659,520.661,525.161,529.157,531.659,534.161,538.661,542.657" svgx:width="0.5,0.44,0.5,0.5,0.28,0.44,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.25,0.5,0.33,0.25,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">people with clinically isolated syndrome suggestive of demyelina-</text>
   <text y="242.073" x="310.016,312.518,315.02,319.52,324.02,325.685,328.682,335.18,341.183,347.681,353.684,359.183,364.682,367.679,369.929,371.594,376.094,381.17,385.67,387.92,392.42,396.92,401.42,405.92,408.17,409.835,412.832,417.332,418.997,422.993,427.493,431.993,434.495,437.492,441.488,444.989,447.491,449.741,451.406,455.906,460.406,462.071,466.571,469.073,471.908,474.905,478.901,481.898,485.894,490.394,494.39,498.386,500.042,506.54,510.536,514.037,515.702,520.202,524.198,526.7,530.696,534.692,537.194,541.19,545.69" svgx:width="0.28,0.28,0.5,0.5,0.25,0.33,0.72,0.67,0.72,0.67,0.61,0.61,0.33,0.25,0.25,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.33,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.25,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion (ORACLE), p=0.0012. In contrast, no difference was detected </text>
   <text y="253.071" x="310.016,314.516,318.512,321.014,327.512,331.508,335.504,340.004,342.254,343.289,347.285,351.281,355.781,359.777,363.773,366.77,369.02,370.055,373.052,377.048,379.55,383.546,387.047,389.297,390.332,392.834,397.334,399.584,400.619,403.121,407.621,411.617,413.867,414.902,417.404,420.401,424.397,428.393,430.895,437.897,441.893,446.393,448.895,451.145,452.18,456.68,459.677,464.177,468.677,473.177,476.678,478.928,479.963,484.463,487.46,489.71,490.745,496.748,502.247,508.745,514.748,517.745,523.244,529.409,531.659,532.694,536.69,541.19,545.69" svgx:width="0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.61,0.72,0.67,0.33,0.61,0.72,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">between cancer rates in the treatment groups of CLARITY and </text>
   <text y="264.069" x="310.016,316.514,322.517,329.015,335.018,340.517,346.016,348.266,351.263,355.763,360.839,365.339,368.336" svgx:width="0.72,0.67,0.72,0.67,0.61,0.61,0.25,0.33,0.5,0.56,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ORACLE (p=1).</text>
   <text y="275.067" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="275.067" x="363.98,370.478,374.978,377.975,380.225,382.43,385.931,388.433,392.933,397.433,401.933,404.183,406.388,409.889,414.389,418.889,423.389,427.385,430.886,433.388,436.889,439.139,441.344,445.34,447.842,451.838,456.338,459.335,461.837,466.337,468.839,473.339,477.335,479.585,481.79,484.292,488.792,491.042,493.247,497.747,502.247,505.748,509.744,513.245,515.495,517.7,522.2,525.701,529.697,534.197,536.447,538.652,541.154,545.654" svgx:width="0.72,0.5,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.39,0.25,0.55,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.39,0.44,0.39,0.25,0.55,0.5,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Our study suggests cladribine in doses used in </text>
   <text y="286.065" x="310.016,316.019,321.518,328.016,334.019,337.016,342.515,348.68,351.479,355.475,359.975,364.475,367.274,373.772,379.775,386.273,392.276,397.775,403.274,406.073,410.573,415.073,419.069,422.57,425.369,429.869,434.369,436.871,439.67,442.172,446.672,450.668,453.665,457.661,461.657,465.158,469.154,471.953,474.455,478.955,482.951,485.75,488.747,491.249,494.75,499.25,502.049,506.549,509.546,512.345,516.341,520.337,524.837,528.833,532.829,535.826,538.625,541.127,545.627" svgx:width="0.67,0.61,0.72,0.67,0.33,0.61,0.72,0.25,0.44,0.5,0.5,0.25,0.72,0.67,0.72,0.67,0.61,0.61,0.25,0.5,0.5,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CLARITY and ORACLE does not increase the risk of cancer in </text>
   <text y="297.063" x="310.016,314.516,321.014,327.017,335.018,340.022,342.272,344.567,350.066,354.566,358.562,361.019,363.521,370.523,375.023,378.02,382.016,385.517,389.018,391.52,396.02,400.52,402.977,405.479,409.979,413.975,416.477,418.934,421.436,423.938,426.395,432.893,437.393,441.893,444.395,448.895,451.352,455.348,459.848,464.348,468.344,472.34,475.337,478.838,481.295,485.795,488.792,491.294,495.794,499.79,504.29,506.747,511.247,515.747,518.204,522.2,526.7,529.157,533.657,538.157,542.657" svgx:width="0.5,0.72,0.67,0.89,0.56,0.25,0.25,0.61,0.5,0.44,0.25,0.28,0.78,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.28,0.25,0.72,0.5,0.5,0.28,0.5,0.25,0.44,0.5,0.5,0.44,0.44,0.33,0.39,0.25,0.5,0.33,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.25,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pwRMS. The impression that it would appears driven by an unu-</text>
   <text y="308.061" x="310.016,313.517,318.017,322.013,324.515,327.017,331.517,333.767,334.532,337.034,341.534,348.032,350.282,351.047,355.043,359.039,363.539,367.535,371.531,374.528,376.778,377.534,380.531,384.527,387.029,391.025,393.275,394.031,396.533,401.033,403.283,404.048,406.55,411.05,415.046,417.296,418.061,422.561,425.063,429.059,433.055,437.051,441.551,446.051,448.301,449.066,453.566,456.563,461.063,465.563,470.063,472.313,473.069,477.569,480.566,482.816,483.581,489.584,495.083,501.581,507.584,510.581,516.08,521.417,523.667,525.917,526.682,532.181,536.681,541.181,545.681" svgx:width="0.39,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.72,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.61,0.72,0.67,0.33,0.61,0.72,0.25,0.25,0.55,0.61,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sually low cancer rate in the placebo group of CLARITY. Long </text>
   <text y="319.059" x="310.016,312.518,316.514,319.511,326.513,329.366,332.363,336.863,339.365,341.867,346.367,352.865,355.862,360.362,364.862,367.715,374.213,376.715,379.217,381.719,384.572,389.072,393.068,395.57,400.07,402.932,407.432,411.428,413.93,417.926,420.923,427.925,430.427,434.927,438.923,441.776,444.278,448.778,452.774,455.627,459.623,463.619,468.119,472.115,476.111,479.108,481.961,484.958,487.46,490.961,495.461,498.314,502.814,505.811,508.664,512.66,515.162,517.664,520.517,527.015,535.016,539.885,543.386,545.636" svgx:width="0.28,0.44,0.33,0.78,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.72,0.28,0.28,0.28,0.25,0.5,0.44,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.44,0.28,0.28,0.25,0.72,0.89,0.61,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">term follow-up will help determine the cancer risk of all DMTs. </text>
   <text y="330.057" x="310.016,316.514,319.016,323.516,327.512,332.012,334.469,336.971,339.473,342.974,345.431,349.427,352.262,355.259,357.761,361.757,365.753,369.749,373.664,375.914,378.371,380.873,385.373,387.875,391.871,394.868,398.864,403.364,405.866,408.368,410.87,413.372,417.872,420.329,424.325,428.825,433.325,435.782,439.778,444.278,448.778,453.278,457.274,461.774,464.276,468.272,472.772,476.768,480.764,483.221,487.217,489.719,493.715,498.215,501.212,503.714,508.214,510.716,515.216,519.212,521.669,525.17,529.67,534.17,538.67,541.172,545.672" svgx:width="0.72,0.28,0.5,0.44,0.5,0.25,0.28,0.28,0.39,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.25,0.28,0.5,0.28,0.44,0.33,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.44,0.25,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.39,0.5,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Given its efficacy, tolerability and convenience cladribine should </text>
   <text y="341.055" x="310.016,314.516,318.512,320.762,323.759,327.755,331.751,336.251,340.751,344.252,346.754,351.254,355.25,358.247,362.243,366.743,368.993,371.99,376.49,379.487,381.737,384.239,387.236,391.232,395.228,397.73,404.732,408.728,413.228,415.73,417.98,422.48,425.477,427.727,432.227,438.725,444.728,452.729,457.733" svgx:width="0.5,0.44,0.25,0.33,0.44,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.5,0.72,0.67,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">be reconsidered for treatment of pwRMS.</text>
   <text y="368.055" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P888</text>
   <text y="379.053" x="310.016,315.515,318.017,323.021,327.521,332.021,334.523,337.025,344.522,349.022,354.026,356.276,360.776,363.773,366.77,370.766,374.762,377.012,382.016,386.516,389.513,394.013,396.515,399.017,403.013,408.017,415.514,420.014,425.018,427.268,430.265,432.515,436.016,439.517,441.767,444.764,449.768,453.764,457.76,461.756,464.006,468.506,470.756,474.752,478.748,483.752,488.252,493.256,498.26,503.264,505.514,510.014,513.011" svgx:width="0.61,0.28,0.56,0.5,0.5,0.28,0.28,0.83,0.5,0.56,0.25,0.5,0.33,0.33,0.44,0.44,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.25,0.33,0.25,0.39,0.39,0.25,0.33,0.56,0.44,0.44,0.44,0.25,0.5,0.25,0.44,0.44,0.56,0.5,0.56,0.56,0.56,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Fingolimod after natalizumab - Is there a rebound of </text>
   <text y="390.051" x="310.016,318.512,323.516,325.766,330.266,334.262,337.259,339.761,344.261,346.763,349.76,354.26" svgx:width="0.94,0.56,0.25,0.5,0.44,0.33,0.28,0.5,0.28,0.33,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">MS activity?</text>
   <text y="401.049" x="310.016,313.013,319.016,321.266,329.267,333.263,336.26,340.76,345.26,349.256" svgx:width="0.33,0.67,0.25,0.89,0.44,0.33,0.5,0.5,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">IB Marques</text>
   <text y="398.583" x="352.756" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="401.103" x="355.681,357.931,360.181,363.178,365.428,371.431,375.931,378.928,381.925,385.921,388.423" svgx:width="0.25,0.25,0.33,0.25,0.67,0.5,0.33,0.33,0.44,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, I Correia</text>
   <text y="398.583" x="392.419" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="401.103" x="395.344,397.594,399.844,404.848,407.098,413.101,417.097,419.599,422.101,425.602,428.104" svgx:width="0.25,0.25,0.56,0.25,0.67,0.44,0.28,0.28,0.39,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Batista</text>
   <text y="398.583" x="432.099" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="401.103" x="435.024,437.274,439.524,445.527,447.777,454.275,458.775,463.275,467.271" svgx:width="0.25,0.25,0.67,0.25,0.72,0.5,0.5,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Nunes</text>
   <text y="398.583" x="470.772" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="401.103" x="473.697,475.947,478.197,486.198,492.201,494.451,502.452,506.448,510.444,514.44,517.437,519.939" svgx:width="0.25,0.25,0.89,0.67,0.25,0.89,0.44,0.44,0.44,0.33,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MC Macario</text>
   <text y="398.583" x="524.438" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="401.103" x="527.363,529.613" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="412.101" x="310.013,315.512,317.762,322.766,327.266,331.766,335.267" svgx:width="0.61,0.25,0.56,0.5,0.5,0.39,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">L Sousa</text>
   <text y="409.583" x="339.266" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="420.581" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="423.103" x="312.941,318.944,323.444,325.946,332.444,336.944,340.445,344.945,347.195,353.693,358.193,360.695,364.691,368.687,372.188,375.689,378.191,380.693,384.689,386.939,393.437,397.937,401.438,405.938,408.44,410.942,415.442,417.944,420.194,422.444,428.942,432.938,437.438,441.938,445.439,447.941,454.439,458.435,462.935,465.437,467.687,472.187,474.689,476.939,482.942,486.938,491.438,494.939,499.439,501.941,506.441,510.941,514.937,517.187" svgx:width="0.67,0.5,0.28,0.72,0.5,0.39,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Coimbra University Hospital, Department of Neurology, </text>
   <text y="434.101" x="310.016,316.019,320.519,323.021,329.519,334.019,337.52,342.02,344.27,346.52,352.019,356.519,360.02,362.522,367.022,371.522,376.022" svgx:width="0.67,0.5,0.28,0.72,0.5,0.39,0.5,0.25,0.25,0.61,0.5,0.39,0.28,0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Coimbra, Portugal</text>
   <text y="461.101" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="461.101" x="364.475,372.476,376.472,380.972,385.472,387.722,389.585,394.085,398.081,400.583,403.085,407.081,411.581,414.083,417.584,419.834,421.697,428.195,430.697,433.199,437.699,439.949,441.812,449.813,454.313,456.815,459.317,461.819,466.319,468.821,472.817,475.067,476.93,481.934,485.93,488.432,492.428,495.425,499.925,503.426,505.928,509.429,511.679,513.542,516.539,524.54,529.544,532.541,534.791,536.654,541.154,545.654" svgx:width="0.89,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.56,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Many patients with Multiple Sclerosis (MS) on </text>
   <text y="472.099" x="310.016,316.514,320.51,323.012,327.008,329.51,332.012,336.008,340.508,347.51,351.506,356.006,358.256,360.461,363.458,369.956,375.455,380.954,383.951,386.201,388.406,392.402,395.399,399.395,401.645,403.85,408.35,412.346,414.848,419.348,423.848,426.098,428.303,431.804,438.302,440.804,443.306,447.302,451.802,455.798,460.298,462.548,464.753,467.255,471.755,474.005,476.21,481.214,483.716,488.216,492.716,497.216,499.718,502.22,509.222,513.722,518.222,520.472,522.677,525.674,530.678,536.177,542.675,545.672" svgx:width="0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.33,0.72,0.61,0.61,0.33,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.39,0.72,0.28,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.33,0.56,0.61,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natalizumab (NTZ) are being switched to Fingolimod (FTY) </text>
   <text y="483.097" x="310.016,314.516,318.512,322.508,326.504,331.004,334.505,338.501,340.751,344.954,349.454,352.451,354.701,358.904,362.405,366.401,369.398,373.394,375.896,380.396,382.646,386.849,389.351,392.852,396.353,400.853,404.849,408.35,410.6,414.803,417.8,421.796,424.298,428.294,430.796,434.792,439.292,441.542,445.745,448.247,452.747,454.997,459.2,464.204,467.201,471.701,476.201,479.198,483.194,486.695,490.196,492.698,497.198,501.194,503.444,507.647,515.648,520.148,522.65,525.152,527.654,530.651,535.151,539.147,543.143,545.645" svgx:width="0.5,0.44,0.44,0.44,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.28,0.39,0.39,0.5,0.44,0.39,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.56,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.89,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">because of safety issues related to Progressive Multifocal </text>
   <text y="494.095" x="310.016,315.515,319.511,324.011,328.007,332.507,336.503,341.003,344.999,348.995,353.495,357.995,361.991,364.493,368.993,373.493,377.489,379.991,384.491,388.991,391.466,394.463,396.965,400.466,404.966,407.216,409.529,415.028,419.528,423.524,425.999,429.5,433.496,436.493,440.489,442.991,447.491,449.966,453.962,458.462,462.962,465.437,469.433,472.268,475.265,477.767,481.763,485.759,489.755,494.255,496.73,501.23,504.227,506.702,509.204,513.704,516.206,519.707,522.182,525.683,532.181,534.683,537.185,541.181,545.681" svgx:width="0.61,0.44,0.5,0.44,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.33,0.28,0.39,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.39,0.72,0.28,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Leucoencephalopathy risk. The safety and efficacy of this switch </text>
   <text y="505.093" x="310.016,312.518,316.019,318.269,319.151,323.651,328.151,332.651,337.151,341.651,348.149,352.649,354.899,355.781,359.777,364.277,368.777,371.027,371.909,374.411,378.911,382.907,385.157,386.039,390.539,395.039,398.54,402.041,404.543,409.043,411.545,414.047,416.549,419.051,423.551,425.801,426.683,431.183,434.18,436.43,437.312,441.812,444.314,447.815,451.811,455.807,459.308,463.304,465.554,466.436,470.432,474.428,476.93,479.432,483.932,486.434,488.936,493.436,495.686,496.568,499.565,503.561,508.061,512.561,517.061,521.561,526.061,528.311,529.193,533.189,536.186,538.688,542.684,545.681" svgx:width="0.28,0.39,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.72,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.39,0.39,0.28,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">is unknown and the possibility of disease activity rebound after </text>
   <text y="516.091" x="310.016,312.518,317.018,321.014,323.264,326.765,333.263,335.765,338.267,342.263,346.763,349.013,351.515,355.016,357.266,361.262,363.512,367.508,372.008,375.005,378.002,381.998,386.498,389.0,391.25,395.246,399.746,404.246,408.242,412.238,415.235,419.735" svgx:width="0.28,0.5,0.44,0.25,0.39,0.72,0.28,0.28,0.44,0.5,0.25,0.28,0.39,0.25,0.44,0.25,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.44,0.44,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the switch is a current concern.</text>
   <text y="527.089" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="527.089" x="355.565,361.064,365.564,369.56,372.062,376.562,380.558,383.06,387.056,389.117,391.619,396.119,400.115,402.176,406.172,408.674,411.176,415.676,418.178,422.174,426.17,428.672,430.733,433.73,437.726,441.227,445.727,450.227,454.727,458.228,462.224,464.285,466.787,471.287,473.348,478.352,483.851,490.016,492.077,494.579,499.079,501.14,505.64,509.636,512.138,514.64,518.636,523.136,525.638,529.139,531.2,535.7,538.697,542.693" svgx:width="0.61,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.28,0.5,0.25,0.56,0.61,0.72,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Evaluate the clinical response to FTY in patients pre-</text>
   <text y="538.087" x="310.016,314.516,317.018,321.518,326.018,329.519,332.021,336.521,338.906,341.408,344.405,348.401,352.397,354.899,358.895,363.395,365.78,372.278,374.78,377.282,381.782,384.167,390.665,396.164,401.663,403.913,405.803,412.301,415.802,419.303,423.299,426.8,430.301,432.686,437.186,440.183,444.179,448.679,451.181,455.177,457.679,462.179,465.176,468.677,471.062,475.562,478.559,480.944,483.941,487.937,490.439,494.435,498.935,502.436,506.432,508.817,513.317,516.314,518.699,523.199,525.701,529.202,533.198,537.698,540.2,542.702" svgx:width="0.5,0.28,0.5,0.5,0.39,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.61,0.61,0.25,0.25,0.72,0.39,0.39,0.44,0.39,0.39,0.25,0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.5,0.33,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">viously treated with NTZ. Assess predictors of relapse or disabil-</text>
   <text y="549.085" x="310.016,312.518,315.02,319.52,321.77,326.27,329.267,333.767,338.267,341.264,345.26,348.761,352.262,354.764,359.264,363.764,366.014,370.514,375.014,378.011,380.513,385.013,389.513,391.763,396.767,402.266,408.431,410.681,413.183,416.18,420.176,424.172,426.674,433.676,437.672,442.172,444.674" svgx:width="0.28,0.28,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.56,0.61,0.72,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ity progression during FTY treatment.</text>
   <text y="560.083" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="560.083" x="349.157,355.16,359.156,361.658,364.655,369.155,372.656,377.156,381.152,385.148,387.65,390.152,394.652,398.648,401.294,404.291,408.287,412.787,415.289,419.285,425.783,428.429,432.929,435.926,438.572,442.568,445.07,447.572,452.072,454.574,458.57,462.566,465.068,467.714,471.71,476.21,480.206,483.203,485.705,489.206,491.852,496.352,499.349,501.995,509.996,515.0,517.646,522.146,526.142,528.644,531.146,535.142,539.642,542.144,545.645" svgx:width="0.67,0.44,0.28,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.44,0.5,0.28,0.44,0.72,0.25,0.5,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.33,0.28,0.39,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Retrospective review of clinical charts of MS patients </text>
   <text y="571.081" x="310.016,312.518,315.515,319.511,323.507,326.009,330.005,334.505,337.178,340.175,344.675,347.672,350.345,354.845,357.518,364.52,369.02,373.52,376.022,380.522,384.023,386.696,393.194,395.696,398.198,402.698,405.371,410.375,415.874,422.039,424.712,428.708,431.705,434.207,438.203,441.2,443.873,450.371,455.87,461.369,463.619,466.292,472.295,474.797,477.299,481.799,484.301,488.297,492.293,494.795,497.468,500.465,504.461,507.962,512.462,516.962,521.462,524.963,528.959,531.632,538.13,542.126,545.627" svgx:width="0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.56,0.61,0.72,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.72,0.61,0.61,0.25,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treated for 6 months with FTY after NTZ. Clinical response was </text>
   <text y="582.079" x="310.016,314.012,317.513,321.014,325.01,328.511,332.012,336.008,340.508,342.758,343.532,348.032,352.028,355.529,359.525,364.025,366.275,367.049,371.549,376.049,378.299,379.073,383.069,387.569,392.069,396.569,400.565,403.067,405.569,409.565,413.561,418.061,420.311,421.085,424.082,428.078,430.58,434.576,439.076,442.577,446.573,448.823,449.597,452.594,456.59,459.092,463.088,465.338,466.112,469.109,475.607,481.61,487.613,490.61,492.86,493.634,497.63,502.13,506.63,508.88,509.654,515.153,519.653,524.153,528.149,532.649,537.149,541.145,545.645" svgx:width="0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.5,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.25,0.55,0.33,0.72,0.67,0.67,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">assessed based on annualized relapse rate (ARR) and Expanded </text>
   <text y="593.077" x="310.016,316.514,319.016,322.517,326.513,331.013,333.515,336.017,338.519,341.021,345.521,347.6,352.604,355.106,359.102,361.604,366.104,369.605,371.684,376.688,380.684,384.68,387.182,391.178,393.257,396.254,401.753,408.251,413.255,418.259,421.256,423.335,426.836,430.832,435.332,438.329,442.325,444.575,446.654,451.658,454.16,458.156,460.658,463.16,466.661,469.163,471.665,475.661,479.657,482.159,484.229,488.225,492.725,496.721,499.223,503.723,507.224,509.726,513.227,515.306,521.804,525.8,529.301,531.38,535.88,539.876,542.675" svgx:width="0.72,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.56,0.28,0.44,0.28,0.5,0.39,0.25,0.56,0.44,0.44,0.28,0.44,0.25,0.33,0.61,0.72,0.56,0.56,0.33,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.25,0.56,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Disability Status Scale (EDSS) score. Statistical analysis was per-</text>
   <text y="604.075" x="310.016,313.013,317.513,320.51,327.512,331.508,336.008,338.258,342.758,346.259,348.761,353.261,357.761,360.011,365.015,370.019,375.023,380.027,382.277,385.778,390.278,393.275,395.777,402.275,406.271,409.268,413.264" svgx:width="0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.56,0.56,0.56,0.56,0.25,0.39,0.5,0.33,0.28,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">formed using SPSS software.</text>
   <text y="615.073" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="615.073" x="344.882,349.382,353.882,356.132,357.752,362.252,366.248,368.75,371.252,375.248,379.748,382.25,385.751,388.001,389.621,396.119,400.115,403.112,407.108,409.358,410.978,414.479,420.977,423.479,425.981,429.977,434.477,438.473,442.973,445.223,446.843,449.84,452.837,457.337,464.339,466.589,468.209,474.707,480.206,485.705,487.955,489.575,492.077,496.577,498.827,500.447,505.451,510.95,516.287,518.537,520.787,522.407,526.907,531.407,533.657,538.157,545.654" svgx:width="0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.72,0.28,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.72,0.61,0.61,0.25,0.55,0.28,0.5,0.25,0.55,0.56,0.61,0.72,0.25,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">29 patients were switched from NTZ to FTY, 89.7% </text>
   <text y="626.071" x="310.016,314.516,318.512,322.508,326.504,331.004,334.505,338.501,341.255,345.755,348.752,351.506,356.006,360.506,364.007,366.509,369.011,371.513,376.013,380.009,382.763,386.264,392.267,395.021,399.521,402.023,405.02,409.52,413.021,415.775,419.771,424.271,426.773,429.275,433.775,438.275,442.775,446.69,448.94,451.694,456.194,458.444,462.944,470.441,473.195,477.191,480.188,482.69,486.686,489.683,492.437,496.433,500.933,505.433,509.429,512.426,515.927,519.923,522.677,526.673,531.173,535.169,539.669,542.171,545.672" svgx:width="0.5,0.44,0.44,0.44,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.25,0.5,0.83,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">because of positive JC virus antibody, 3.4% after adverse events </text>
   <text y="637.069" x="310.016,314.012,318.512,323.012,325.928,330.428,332.678,337.178,344.675,347.591,352.091,356.087,360.083,364.079,368.579,372.08,376.076,378.992,383.492,386.489,389.405,391.907,396.407,400.403,403.238,406.235,408.737,412.733,416.729,420.725,424.64,426.89,429.644,435.143,439.643,443.639,446.555,453.557,457.553,461.549,466.049,468.965,472.961,477.461,481.457,484.364,488.36,490.862,493.778,501.779,506.783,509.699,514.199,518.195,522.695,525.197,529.697,534.197,536.699,541.199,545.699" svgx:width="0.44,0.5,0.5,0.25,0.5,0.25,0.5,0.83,0.25,0.5,0.44,0.44,0.44,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.25,0.44,0.28,0.25,0.89,0.56,0.25,0.5,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 6.9% because of inefficacy. The mean age at MS beginning </text>
   <text y="648.067" x="310.016,316.514,320.51,324.011,326.441,330.941,335.441,337.691,342.191,347.132,351.632,353.882,358.382,360.812,365.312,369.308,373.304,376.301,379.802,382.223,386.219,390.719,395.219,397.649,400.151,404.651,408.647,411.077,418.079,422.075,426.071,430.571,432.992,437.492,441.992,444.989,448.985,451.487,453.989,458.489,462.989,465.419,469.919,472.916,475.346,481.844,487.343,492.842,495.272,497.774,500.771,504.767,508.763,511.265,518.267,522.263,526.763,529.265,531.686,538.184,542.18,545.681" svgx:width="0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.61,0.61,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was 27.5Â±8.9 years and the mean duration of NTZ treatment was </text>
   <text y="659.065" x="310.016,314.516,319.016,321.266,325.766,330.707,335.207,339.707,341.957,346.457,348.293,355.295,359.795,364.295,366.797,371.297,374.798,377.048,378.389,384.887,387.389,389.225,394.229,399.728,405.893,407.729,412.229,416.729,420.23,424.226,426.728,428.564,431.066,435.566,439.562,441.398,448.4,452.396,456.392,460.892,462.728,466.724,471.224,475.22,477.056,483.554,487.55,491.051,492.887,497.387,501.887,504.137,508.637,513.578,518.078,520.328,524.828,526.664,531.164,535.16,539.156,542.153,545.654" svgx:width="0.5,0.5,0.25,0.5,0.55,0.5,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.72,0.28,0.25,0.56,0.61,0.72,0.25,0.5,0.5,0.39,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">28.7Â±14.9 months. At FTY onset the mean age was 38.2Â±8.6 years </text>
   <text y="670.063" x="310.016,314.012,318.512,323.012,325.262,327.305,329.807,334.307,338.303,340.553,342.596,349.598,353.594,357.59,362.09,364.34,366.383,370.883,373.385,376.886,380.882,384.878,388.379,392.375,394.625,396.668,401.168,405.668,408.665,412.661,415.163,417.665,422.165,426.665,428.915,430.958,437.456,441.452,444.953,447.203,449.246,453.746,458.246,460.496,464.996,469.937,474.437,476.687,481.187,483.437,485.687,487.568,493.067,497.567,501.563,503.813,505.856,512.858,516.854,520.85,525.35,527.6,529.643,532.145,534.647,541.649,545.645" svgx:width="0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.28,0.28,0.78,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and the mean disease duration was 10.4Â±6.4. The mean time </text>
   <text y="681.061" x="310.016,314.516,318.512,321.014,327.512,331.508,335.504,340.004,342.254,343.703,346.205,350.705,354.701,356.951,358.4,360.902,364.898,368.399,370.901,373.151,374.6,381.098,386.597,392.096,394.346,395.795,398.297,402.797,405.794,410.294,413.795,416.297,420.797,425.297,427.547,428.996,432.992,437.492,441.992,444.242,445.691,448.193,452.693,456.689,458.939,460.388,464.888,468.884,473.384,475.886,480.386,484.886,487.388,491.888,496.388,498.638,500.087,504.587,507.584,509.834,511.283,516.287,521.786,527.951,530.201,531.65,538.148,542.144,545.645" svgx:width="0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.39,0.28,0.25,0.55,0.72,0.61,0.61,0.25,0.55,0.28,0.5,0.33,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.61,0.72,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">between the last NTZ infusion and the beginning of FTY was </text>
   <text y="692.059" x="310.016,314.516,316.766,321.266,326.207,330.707,332.957,337.457,339.707,342.902,349.904,354.404,358.904,361.406,365.906,369.407,371.657,374.852,378.848,383.348,387.848,390.098,393.293,395.795,400.295,404.291,406.541,409.736,416.738,420.734,424.73,429.23,431.48,434.675,439.679,445.178,451.343,453.593,456.788,459.29,462.287,466.283,470.279,472.781,479.783,483.779,488.279,490.781,493.031,496.226,500.726,505.226,508.223,512.219,514.721,517.223,521.723,526.223,528.473,531.668,538.166,542.162,545.663" svgx:width="0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.56,0.61,0.72,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">2.3Â±1.8 months and the mean FTY treatment duration was </text>
   <text y="703.057" x="310.016,314.516,319.016,321.266,325.766,330.707,335.207,337.457,341.957,344.207,351.209,355.709,360.209,362.711,367.211,370.712" svgx:width="0.5,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">17.4Â±6.6 months.</text>
   <text y="714.055" x="322.013,328.511,331.508,334.01,338.006,341.003,343.253,345.287,347.789,352.289,356.285,358.535,360.569,364.07,370.568,373.07,375.572,379.568,384.068,386.318,388.352,390.854,395.354,397.604,399.638,404.642,410.141,415.478,417.728,419.978,422.012,424.514,429.014,433.01,435.26,436.799,443.297,449.3,455.303,457.553,459.587,464.087,468.083,472.079,475.076,479.072,483.068,486.569,490.565,495.065,497.315,499.349,501.851,506.351,508.601,510.635,515.135,519.635,521.885,526.385,533.882,536.132,538.166,542.666,545.663" svgx:width="0.72,0.33,0.28,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.72,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.56,0.61,0.72,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.67,0.67,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">After the switch to FTY, the ARR decreased in 20.7% of </text>
   <text y="725.053" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015,340.265,342.74,346.736,351.236,355.736,357.986,360.47,362.972,367.472,371.468,374.465,378.461,382.457,385.958,389.954,394.454,396.704,399.179,401.681,406.181,408.431,410.915,415.415,419.915,427.412,429.662,431.912,434.387,440.885,443.387,445.889,450.389,454.889,459.389,461.891,464.141,466.625,470.126,472.628,477.128,481.628,484.13,487.127,489.629,493.625,497.621,502.121,504.623,506.873,509.348,513.848,516.35,519.185,522.182,526.178,529.175,533.171,537.671,541.667,545.663" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.83,0.25,0.25,0.55,0.72,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients and increased in 31%, without significant difference </text>
  </g>
 </g>
</svg>
